Preliminary results from the first six patients taking part in a Phase One trial surprised and delighted the Oxford University team.
Although the trial was only designed to test safety and dosages, two men with relatively advanced disease experienced dramatic improvements to their eyesight.
The researchers are now planning a larger Phase II trial that will focus on the therapy's effectiveness.
More top news
Pregnant women who smoke are more likely to give up if they are given shopping vouchers, new research suggests.
Children are eating the equivalent of seven and a half chocolate fingers for breakfast, campaigners have warned.
Stephen Fry has suggested that the "the patter of tiny feet" may be on the agenda following his wedding to Elliot Spencer.